Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial

Disturbed copper (Cu) homeostasis may be associated with the pathological processes in Alzheimer’s disease (AD). In the present report, we evaluated the efficacy of oral Cu supplementation in the treatment of AD in a prospective, randomized, double-blind, placebo-controlled phase 2 clinical trial in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kessler, Holger, Bayer, Thomas A., Bach, Daniela, Schneider-Axmann, Thomas, Supprian, Tillmann, Herrmann, Wolfgang, Haber, Manfred, Multhaup, Gerd, Falkai, Peter, Pajonk, Frank-Gerald
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Vienna 2008
Assuntos:
Alzheimer's Disease and Related Disorders - Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2516533/
https://ncbi.nlm.nih.gov/pubmed/18587525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00702-008-0080-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados